The role of nonmyocardial cells in the development of diabetic cardiomyopathy and the protective effects of FGF21: a current understanding
Open Access
- 26 September 2024
- journal article
- review article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 22 (1) , 1-23
Abstract
Diabetic cardiomyopathy (DCM) represents a unique myocardial disease originating from diabetic metabolic disturbances that is characterized by myocardial fibrosis and diastolic dysfunction. While recent research regarding the pathogenesis and treatment of DCM has focused primarily on myocardial cells, nonmyocardial cells—including fibroblasts, vascular smooth muscle cells (VSMCs), endothelial cells (ECs), and immune cells—also contribute significantly to the pathogenesis of DCM. Among various therapeutic targets, fibroblast growth factor 21 (FGF21) has been identified as a promising agent because of its cardioprotective effects that extend to nonmyocardial cells. In this review, we aim to elucidate the role of nonmyocardial cells in DCM and underscore the potential of FGF21 as a therapeutic strategy for these cells.Keywords
Funding Information
- Sichuan Science and Technology Program (2022YFS0630, 2022YFS0627, 2022YFS0578)
- National Natural Science Foundation of China (U23A20398)
- the Central Government Guides Local Science and Technology Development Project (2022ZYD0057)
- Natural Science Foundation of Sichuan Province (2024NSFSC0580)
- Applied Basic Research Program of Sichuan Province (2021YJ0200, 2023NSFSC1840)
- Science and Technology Project of Luzhou Government (2022YFS0627-A1, 2022YFS0630-B1)
- Southwest Medical University (2021ZKMS005, 2022QN013)
This publication has 198 references indexed in Scilit:
- Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin EAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Direct effects of high glucose and insulin on protein synthesis in cultured cardiac myocytes and DNA and collagen synthesis in cardiac fibroblastsMetabolism, 2004
- Coupling of Cardiac Electrical Activity Over Extended Distances by Fibroblasts of Cardiac OriginCirculation Research, 2003
- Hyperglycemia-Induced Apoptosis in Mouse MyocardiumDiabetes, 2002
- Signals via FGF Receptor 2 Regulate Migration of Endothelial CellsBiochemical and Biophysical Research Communications, 2001
- Identification of a novel FGF, FGF-21, preferentially expressed in the liverBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2000
- Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells.Diabetes, 1999
- Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.Journal of Clinical Investigation, 1991
- Cardiac lysosomal derangements in mouse heart after long-term exposure to nonmetabolizable sugars.Circulation Research, 1977
- New type of cardiomyopathy associated with diabetic glomerulosclerosisThe American Journal of Cardiology, 1972